A puzzling observation is why peripheral nerve injury results in chronic pain in some, but not all, patients. We explored potential mechanisms that may prevent the expression of chronic pain. Sprague Dawley (SD) or Holtzman (HZ) rats showed no differences in baseline sensory thresholds or responses to inflammatory stimuli. However, spinal nerve ligation (SNL)-induced tactile allodynia occurred in approximately 85% of SD and 50% of HZ rats, respectively. No apparent differences were observed in a survey of dorsal root ganglion or spinal neuropathic markers after SNL regardless of allodynic phenotype. SNL-induced allodynia was reversed by administration of lidocaine within the rostral ventromedial medulla (RVM), a site that integrates descending pain modulation via pain inhibitory (ie, OFF) and excitatory (ie, ON) cells. However, in SD or HZ rats with SNL but without allodynia, RVM lidocaine precipitated allodynia. Additionally, RVM lidocaine produced conditioned place preference in allodynic SD or HZ rats but conditioned place aversion in nonallodynic HZ rats. Similarly, RVM U69,593 (kappa opioid agonist) or blockade of spinal a 2 adrenergic receptors precipitated allodynia in previously nonallodynic HZ rats with SNL. All rats showed an equivalent first-phase formalin responses. However, HZ rats had reduced secondphase formalin behaviors along with fewer RVM OFF cell pauses and RVM ON cell bursts. Thus, expression of nerve injury-induced pain may ultimately depend on descending modulation. Engagement of descending inhibition protects in the transition from acute to chronic pain. These unexpected findings might provide a mechanistic explanation for medications that engage descending inhibition or mimic its consequences. Ó
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Introduction
The dominant focus of research on chronic, and especially neuropathic, pain has been on changes in pain-generating or -transmitting mechanisms. However, many patients with peripheral nerve pathologies do not develop significant or persistent pain [55] . For example, only approximately 10% to 26% of patients with diabetes develop painful neuropathies [9, 26, 58] , and only 7% to 27% of patients with herpes zoster rash develop postherpetic neuralgia [31, 70] . Development of neuropathic pain after endodontic procedures [75] or traumatic nerve injury [71] occurs in less than 5% of individuals. In spite of the considerable variability in the susceptibility of individuals to develop neuropathic pain, the reasons for this variability are unknown [50, 55, 68] .
One obstacle to our understanding of the variability of chronic pain resides in the animal models used for the study of neuropathic pain. Most studies of experimental neuropathic pain commonly use rodent strains in which peripheral nerve injury consistently (ie, >90%) produces what seems to be a painful state [6] . However, some rodent strains are resistant to the development of experimental neuropathic pain [47, 82] . As in humans, reasons for the susceptibility and/or resistance to experimental neuropathic pain in rodents are not understood. 
